| 发明名称 |
NANOPARTICLE FORMULATION |
| 摘要 |
The present invention concerns nanoparticle formulations suitable for the delivery of one or more therapeutic agents, the formulations comprising: a cationic cholesterol derivative; a neutral phospholipid; cholesterol or a neutral cholesterol derivative; and a saturated fatty acid, PEGylated neutral derivative of phosphatidylethanolamine or phosphatidylcholine. |
| 申请公布号 |
US2015224054(A1) |
申请公布日期 |
2015.08.13 |
| 申请号 |
US201314424332 |
申请日期 |
2013.08.28 |
| 申请人 |
Medical Research Council ;Imperial Innovations Ltd |
发明人 |
Bell Jimmy;Thomas Elizabeth Louise;Brody Leigh;Arisoylu Meliz Sahuri;Miller Andrew;Frost Gary |
| 分类号 |
A61K9/127;A61K47/24;A61K31/19;A61K47/28 |
主分类号 |
A61K9/127 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A nanoparticle formulation suitable for the delivery of one or more therapeutic agents, the formulation comprising:
i) a cationic cholesterol derivative; ii) a neutral phospholipid; iii) cholesterol or a neutral cholesterol derivative; and iv) a saturated fatty acid, PEGylated neutral derivative of phosphatidylethanolamine or phosphatidylcholine. |
| 地址 |
Swindon, Wiltshire GB |
